Comparison 21. HALOPERIDOL vs COMBINATIONS: f. OLANZAPINE + MAGNESIUM VALPROATE.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Specific behaviour: 1. Agitation ‐ average scores ‐ over 24 hours	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
1.1 endpoint score at 72 hours (PANSS‐EC, high=worse)	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.2 endpoint score at 7 days (PANSS‐EC, high=worse)	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
1.3 endpoint score at 14 days (PANSS‐EC, high=worse)	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 Global outcome: No improvement	1	64	Risk Ratio (M‐H, Fixed, 95% CI)	1.06 [0.38, 2.95]
3 Mental state: Average scores ‐ i. over 24 hours	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected
3.1 endpoint score at 72 hours (PANSS total, high=worse)	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.2 endpoint score at 7 days (PANSS total, high=worse)	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
3.3 endpoint score at 14 days (PANSS total, high=worse)	1		Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Adverse effects: General ‐ over 24 hours	1		Risk Ratio (M‐H, Fixed, 95% CI)	Totals not selected
4.1 one or more drug related adverse effects ‐ by 14 days	1		Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]